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Abstract
Diabetes affects over 100 million people worldwide. Better
methods for monitoring blood glucose levels are needed for
improving disease management. Several labs have previously
made glucose nanosensors by modifying members of the
periplasmic ligand binding protein superfamily. This minire-
view summarizes recent developments in constructing new
versions of these proteins that are responsive within the
physiological range of blood glucose levels, employ new
reporter groups, and/or are more robust. These experiments
are important steps in the development of novel proteins that
have the characteristics needed for an implantable glucose
nanosensor for diabetes management: specificity for glucose,
rapid response, sensitivity within the physiological range of
glucose concentrations, reproducibility, and robustness.
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D
iabetes is a current major health problem that
affects over 100 million people worldwide. Dis-
ease management for many patients requires
frequent measurement of blood glucose concentrations,
which usually requires pricking of a finger to draw a
blood sample. There is great interest in developing new
methods of monitoring glucose levels. Of particular
interest would be an implantable device for continuous
monitoring. New methods would require specificity for
glucose, rapid response, sensitivity to glucose concentra-
tions within a physiological range (1.733 mM) (1),
reproducibility, and robustness.
Protein-based biosensors for detecting specific small
molecules have previously been derived from several
members of the periplasmic ligand binding protein family
(PLBP) (2). The PLBP proteins contain two large
globular domains with a connecting flexible hinge region
(3). Upon ligand binding, the protein undergoes a large
conformational change that brings the two lobes together
with the ligand binding pocket located at the interface of
the two domains (Fig. 1). A method of detecting the
conformational change is attached to the protein, for
example, a fluorescent tag that undergoes a change in
fluorescence when the protein switches between the
ligand bound and unbound conformations. The two
conformations of the PLBP serve as an on/off switch
that can be used to detect bound ligand in a reagentless
manner; no substrate is used up. Several labs have used
this general method to produce variants of the Escher-
ichia coli glucose/galactose-binding protein (GBP) to
serve as biosensors for glucose (413). Recent develop-
ments described below include (1) mutant forms of the
GBP that have binding constants for glucose that are
within the physiological range of blood glucose levels and
increased specificity for glucose over other sugars, (2) the
use of new reporter groups, and (3) the use of a
thermostable GBP from Thermotoga maritima that is
more robust than the E. coli GBP.
One disadvantage of using the E. coli GBP as a glucose
sensor has been its high-binding affinity for glucose,
0.2 mM (14). Modified forms of the protein are needed
that can respond to physiological levels of glucose
without being saturated. Recently, three labs used site-
directed mutagenesis guided by the GBP X-ray crystal
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with changes in the ligand binding pocket that resulted in
a new binding affinity that is within the physiological
range for blood glucose monitoring (Fig. 2) (1517).
A fourth lab used structure-guided random mutagenesis
of a selected region in the ligand binding site and also
successfully created a mutant protein that has a binding
constant for glucose within the physiological range (18).
Another recent development is several GBP-based
sensors with new reporter groups. Der and Dattelbaum
used their mutant GBP protein described above to
develop a glucose biosensor that uses molecular exciton
luminescence as a reporter (16). Two identical rhodamine
derivative tags were covalently bound to cysteines that
were introduced through site-directed mutagenesis at
opposite ends of the glucose-binding cleft (Fig. 3A).
The tags are far apart when the protein has not bound
glucose. Upon glucose binding, the GBP conformational
change brings the two tags close enough so that they form
dimers with altered excitation and fluorescence.
Two labs have developed GBP derivatives with biolu-
minescent reporters to obtain glucose-responsive biolu-
minescence. The Sode lab constructed a hybrid protein
with their modified GBP described above and split
luciferase (19). Two halves of the luciferase protein that
are not individually luminescent are fused to the two
lobes of the GBP (Fig. 3B). When the chimeric protein
binds glucose, it changes conformation and brings the
Fig. 2. Several labs have identiﬁed amino acid substitutions
in or near the glucose binding site of the glucose/galactose
binding protein that adjust the binding afﬁnity to within the
range needed for monitoring blood glucose levels. The
protein backbone is shown as an alpha carbon trace in grey.
Glucose and some of the amino acids that were substituted,
singly or in groups, to alter the binding afﬁnity are shown as
ball-and-stick models. Mutations that brought the binding
afﬁnity into the physiological range include D14E/F16A
(15), R96C/D168C/N211A/A213R (16), H152C/A213R/
L238S (17), and A213R (18).
Fig. 3. Fluorescent or bioluminescent probes attached to the
GBP in appropriate places can undergo changes in ﬂuores-
cence or bioluminescence when the GBP changes conforma-
tion. (A) Two identical ﬂuorescent molecules placed in
appropriate locations are brought together and change
ﬂuorescent properties when the GBP switches from the open
conformation to the closed glucose bound conformation. (B)
The large conformational change in the GBP can also bring
together two domains of a bioluminescent protein, such as
split luciferase or aequorin, so that the reporter protein
becomes luminescent when glucose binds to the GBP.
Fig. 1. The glucose/galactose binding protein undergoes a
large conformational change that brings two lobes together
when glucose is bound. (A) An alpha carbon trace of the
glucose/galactose binding protein in its open form without
glucose (PDB ID 2FWO). (B) Glucose/galactose binding
protein in its closed form with glucose (ball-and-stick model)
bound in the ligand binding pocket (PDB ID 2HPH).
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can reassemble into a bioluminescent protein.
Similarly, the Daunert lab created a hybrid glucose-
responsive bioluminescent protein by using aequorin
(AEQ) as a reporter (20). They identified a large
interdomain loop in the X-ray crystal structure of AEQ
where the glucose binding protein could be inserted,
separating the AEQ into two domains that are not
bioluminescent. Glucose binding to the GBP brings the
two segments of AEQ together, the coelenterazine
cofactor is converted to coelenteriamide, and biolumi-
nescense emission is increased.
In addition to improving the range of sensitivity and
adding novel modes of detection of glucose binding to the
GBP, other important requirements for use as a biosensor
are that the protein is robust enough to be used
repeatedly and it maintains function while immobilized
on a surface. The Hellinga lab identified and solved the
crystal structure of a GBP from the thermophile Thermo-
toga maritima, tmGBP, which does not unfold below
1008C (21). Based on the crystal structure of tmGBP,
they introduced a fluorescent reporter group covalently
bound to cysteines introduced at key positions where
conformational changes due to glucose binding might
affect the fluorescence of the tag. They successfully
demonstrated that changes in fluorescence emission of
the reporter group are indeed coupled to glucose binding
(Fig. 4A). The thermostable GBP is more stable to
storage and can be immobilized on a surface through
biotin coupled to exposed lysines without losing sensitiv-
ity (Fig. 4B). It senses glucose within the range of 130
mM glucose, which includes the range of physiological
glucose levels.
The development of these new GBP-based glucose
nanosensors are important steps toward using modified
proteins to serve as specific, reusable, sensitive, and
robust sensors for the measurement of glucose levels.
They are potentially important steps in the direction of
an implantable continuous glucose monitor that would
aid in the management of diabetes and improve patients’
ability to avoid complications due to hypoglycemia or
hyperglycemia.
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